• News & Media
  • Contact
  • Home
  • About Us
    • Our Commitment
    • The Story Behind Our Name
    • Leadership
    • Board of Directors
    • Grants & Funding
    • Investigator Sponsored Studies
  • Our Approach
    • Precision Medicines
    • Overcoming Resistance
    • Novel Biomarkers
  • Pipeline
    • Ziftomenib
    • Tipifarnib
    • KO-2806
    • Posters and Presentations
    • Scientific Manuscripts
    • Access To Investigational Drugs Outside a Clinical Study
  • Clinical Trials
    • Overview of Clinical Trials
    • Ziftomenib Clinical Trials
    • KOMET-001 – AML
    • KOMET-007 – AML
    • KOMET-008 – AML
    • Tipifarnib Clinical Trials
    • KURRENT-HN – HNSCC
    • KO-2806 Clinical Trials
    • FIT-001 – Solid Tumors
  • Patients & Caregivers
    • Acute Leukemias
    • Head & Neck Cancer
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Analyst Coverage
    • FAQs
    • Contact
  • Careers
    • Values
    • Life At Kura
    • Benefits
    • Open Positions
  • News & Media
  • Contact
  • Menu Menu

Dr. Fathi presents the latest KOMET-001 data

September 19, 2023/in Fathi, videos
Read more
https://kuraoncology.com/wp-content/uploads/Fathi_r2_long_thumbnail.png 640 1137 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2023-09-19 10:54:002023-09-19 10:57:37Dr. Fathi presents the latest KOMET-001 data

NPM1 mutations in acute myeloid leukemia: actionable mutations to inform treatment decisions with clinical trials

August 8, 2023/in Fathi, videos
Read more
https://kuraoncology.com/wp-content/uploads/Fathi_testing_thumbnail.jpg 235 422 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2023-08-08 16:40:522023-08-23 17:06:48NPM1 mutations in acute myeloid leukemia: actionable mutations to inform treatment decisions with clinical trials

Mechanism of action for investigational menin inhibitors, including ziftomenib

August 8, 2023/in Fathi, videos
Read more
https://kuraoncology.com/wp-content/uploads/Mechanism-of-action-for-investigational-menin-inhibitors-including-ziftomenib.jpg 235 422 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2023-08-08 16:12:302023-08-23 17:07:13Mechanism of action for investigational menin inhibitors, including ziftomenib

Can you give a brief overview of unmet medical needs within NPM1-mutated acute myeloid leukemia?

June 16, 2023/in Fathi, videos
Read more
https://kuraoncology.com/wp-content/uploads/Video-2-thumbnail.png 235 422 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2023-06-16 13:47:032023-08-23 17:06:30Can you give a brief overview of unmet medical needs within NPM1-mutated acute myeloid leukemia?

Emerging advancements in acute myeloid leukemia

June 16, 2023/in Fathi, videos
Read more
https://kuraoncology.com/wp-content/uploads/Video-1-thumbnail.png 235 422 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2023-06-16 13:46:022023-08-23 17:46:15Emerging advancements in acute myeloid leukemia
  • About Us
  • Our Commitment
  • The Story Behind Our Name
  • Leadership
  • Board of Directors
  • Grants & Funding
  • Investigator Sponsored Studies
  • Our Approach
  • Precision Medicines
  • Overcoming Resistance
  • Novel Biomarkers
  • Pipeline
  • Ziftomenib
  • Tipifarnib
  • KO-2806
  • Posters and Presentations
  • Scientific Manuscripts
  • Access to Investigational Drugs Outside a Clinical Study
  • Clinical Trials
  • Overview of Clinical Trials
  • Ziftomenib Clinical Trials
  • KOMET-001 – AML
  • KOMET-007 – AML
  • KOMET-008 – AML
  • Tipifarnib Clinical Trials
  • KURRENT-HN – HNSCC
  • KO-2806 Clinical Trials
  • FIT-001 – Solid Tumors
  • Patients & Caregivers
  • Acute Leukemias
  • Head & Neck Cancer
  • Investors
  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financial Information
  • Analyst Coverage
  • FAQs
  • Contact
  • Careers
  • Values
  • Life at Kura
  • Benefits
  • Open Positions
  • News & Media
  • Press Releases
  • News & Perspectives
  • Expert Perspectives
  • Media Resources
  • Contact

Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego, CA 92130
(858) 500-8800

Kura Oncology, Inc.
2 Seaport Lane, Suite 8A
Boston, MA 02210
(617) 588-3755

Kura Oncology, Inc.
5510 Morehouse Drive, Suite 110
San Diego, California 92121

© 2025 Kura Oncology, Inc. All Rights Reserved | Terms of Use | Privacy Policy

Scroll to top Scroll to top Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlySettings

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Accept settingsHide notification only